# United States Oil Fund, LP: financial statements, quarterly

USO · NYSE · CIK 1327068 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uso.md) · [Financials](/companies/uso/financials.md) · [Filings](/companies/uso/filings.md) · [Insiders](/companies/uso/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uso/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [358](/filings/0001410578-25-000228.md) | [(294)](/filings/0001410578-25-000228.md) | [243](/filings/0001104659-26-021501.md) | [22.6](/filings/0001104659-26-021501.md) | [(133)](/filings/0001104659-26-021501.md) | [98.9](/filings/0001104659-26-021501.md) | [42.4](/filings/0001104659-26-057764.md) | [(70.8)](/filings/0001104659-26-092623.md) | [25.6](/filings/0001104659-26-021501.md) | [(53.3)](/filings/0001104659-26-021501.md) | [986](/filings/0001104659-26-057764.md) | [(362)](/filings/0001104659-26-092623.md) |
| Net income | $m | [355](/filings/0001410578-25-000228.md) | [(297)](/filings/0001410578-25-000228.md) | [240](/filings/0001104659-26-021501.md) | [19.9](/filings/0001104659-26-021501.md) | [(135)](/filings/0001104659-26-021501.md) | [96.3](/filings/0001104659-26-021501.md) | [40.3](/filings/0001104659-26-057764.md) | [(73.0)](/filings/0001104659-26-092623.md) | [23.5](/filings/0001104659-26-021501.md) | [(55.5)](/filings/0001104659-26-021501.md) | [984](/filings/0001104659-26-057764.md) | [(365)](/filings/0001104659-26-092623.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [803](/filings/0001410578-24-001827.md) | [952](/filings/0001104659-26-021501.md) | [909](/filings/0001410578-25-001156.md) | [893](/filings/0001410578-25-001643.md) | [1,111](/filings/0001104659-25-108424.md) | [727](/filings/0001104659-26-021501.md) | [783](/filings/0001104659-26-057764.md) | [946](/filings/0001104659-26-092623.md) | [701](/filings/0001104659-25-108424.md) | [652](/filings/0001104659-26-092623.md) | [1,958](/filings/0001104659-26-057764.md) | [1,346](/filings/0001104659-26-092623.md) |
| Total assets | $m | [1,530](/filings/0001410578-23-002210.md) | [1,587](/filings/0001410578-25-000228.md) | [1,464](/filings/0001410578-24-000684.md) | [1,278](/filings/0001410578-24-001237.md) | [1,419](/filings/0001410578-24-001827.md) | [1,099](/filings/0001104659-26-021501.md) | [1,056](/filings/0001410578-25-001156.md) | [1,226](/filings/0001410578-25-001643.md) | [903](/filings/0001104659-25-108424.md) | [890](/filings/0001104659-26-092623.md) | [2,744](/filings/0001104659-26-057764.md) | [1,904](/filings/0001104659-26-092623.md) |
| Total liabilities | $m | [2.0](/filings/0001410578-23-002210.md) | [19.4](/filings/0001410578-25-000228.md) | [41.2](/filings/0001410578-24-000684.md) | [17.5](/filings/0001410578-24-001237.md) | [76.5](/filings/0001410578-24-001827.md) | [10.9](/filings/0001104659-26-021501.md) | [79.6](/filings/0001410578-25-001156.md) | [96.5](/filings/0001410578-25-001643.md) | [18.2](/filings/0001104659-25-108424.md) | [3.5](/filings/0001104659-26-092623.md) | [99.5](/filings/0001104659-26-057764.md) | [150](/filings/0001104659-26-092623.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [283 d](/filings/0001410578-24-001827.md) | [(232) d](/filings/0001104659-26-021501.md) | [170](/filings/0001410578-25-001156.md) | [23.4 d](/filings/0001410578-25-001643.md) | [(71.2) d](/filings/0001104659-25-108424.md) | [53.9 d](/filings/0001104659-26-021501.md) | [25.1](/filings/0001104659-26-057764.md) | [30.4 d](/filings/0001104659-26-092623.md) | [(27.3) d](/filings/0001104659-25-108424.md) | [(50.0) d](/filings/0001104659-26-021501.md) | [632](/filings/0001104659-26-057764.md) | [277 d](/filings/0001104659-26-092623.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 14,823,603 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092623.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.